Ming Tan

8.3k total citations · 3 hit papers
175 papers, 5.4k citations indexed

About

Ming Tan is a scholar working on Statistics and Probability, Molecular Biology and Oncology. According to data from OpenAlex, Ming Tan has authored 175 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Statistics and Probability, 32 papers in Molecular Biology and 29 papers in Oncology. Recurrent topics in Ming Tan's work include Statistical Methods and Inference (40 papers), Statistical Methods in Clinical Trials (37 papers) and Statistical Methods and Bayesian Inference (35 papers). Ming Tan is often cited by papers focused on Statistical Methods and Inference (40 papers), Statistical Methods in Clinical Trials (37 papers) and Statistical Methods and Bayesian Inference (35 papers). Ming Tan collaborates with scholars based in United States, China and Hong Kong. Ming Tan's co-authors include Yinsheng Qu, Michael Kutner, Guo‐Liang Tian, Hong‐Bin Fang, Peter X.‐K. Song, Kevin J. Cullen, Olga Goloubeva, Nicholas J. Sarlis, Robert I. Haddad and Marshall R. Posner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Ming Tan

166 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma phospholipids identify antecedent memory impairment in older adults

2014 782 citations Ming Tan et al. profile →
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

2011 310 citations Jochen H. Lorch, Olga Goloubeva et al. profile →
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

2018 277 citations Ming Tan et al. profile →

Peers

Countries citing papers authored by Ming Tan

Since Specialization

Citations

This map shows the geographic impact of Ming Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Tan more than expected).

Fields of papers citing papers by Ming Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Tan. The network helps show where Ming Tan may publish in the future.

Co-authorship network of co-authors of Ming Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Tan. A scholar is included among the top collaborators of Ming Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Tan. Ming Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term quality of life in head and neck cancer: the role of postdiagnosis smoking behavior 2025 ·Journal of Cancer Survivorship ·Elham Mohebbi, Alaina L. Carr, (unknown), (unknown), E. Clementi, Jonathan P. Giurintano, Matthew E. Witek, Ming Tan, Ruzong Fan, Steven B. Chinn, Gregory T. Wolf, Kristi D. Graves, Peter H. Ahn, Laura S. Rozek	0
2	Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings. 2024 ·Journal of Clinical Oncology ·Benjamin A. Weinberg, (unknown), Allison A. Fitzgerald, Zoe X. Malchiodi, (unknown), Anteneh Tesfaye, Ming Tan, Marcus Smith Noel, Aiwu Ruth He, (unknown), John L. Marshall, (unknown), (unknown), Vincent O’Neill, Louis M. Weiner	2
3	HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane 2022 ·Breast Cancer Research and Treatment ·Paula R. Pohlmann, Deena Graham, (unknown), Yvonne Ottaviano, Mahsa Mohebtash, (unknown), (unknown), Filipa Lynce, Robert Warren, Asma Dilawari, Suman Rao, (unknown), (unknown), Ming Tan, Claudine Isaacs, Sandra M. Swain	4
4	Highly robust causal semiparametric U-statistic with applications in biomedical studies 2022 ·The International Journal of Biostatistics ·Anqi Yin, Ao Yuan, Ming Tan	2
5	Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function 2021 ·Breast Cancer Research and Treatment ·Katia Khoury, Filipa Lynce, Ana Barac, Xue Geng, Chau T. Dang, Anthony F. Yu, Karen L. Smith, Christopher Gallagher, Paula R. Pohlmann, Raquel Nunes, Pia Herbolsheimer, Robert Warren, Monvadi B. Srichai, Mark Hofmeyer, Federico M. Asch, Ming Tan, Claudine Isaacs, Sandra M. Swain	20
6	Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer 2021 ·Cancer ·Filipa Lynce, Matthew Blackburn, (unknown), Christopher Gallagher, Olwen Hahn, Maysa Abu‐Khalaf, Mahsa Mohebtash, (unknown), Paula R. Pohlmann, Asma Dilawari, Shruti Tiwari, (unknown), Robert Warren, Ming Tan, Ayesha N. Shajahan‐Haq, Claudine Isaacs	14
7	A simple and improved score confidence interval for a single proportion 2020 ·Communication in Statistics- Theory and Methods ·(unknown), Ying Xu, Ming Tan, Pingyan Chen, Chongyang Duan	0
8	Targeted design for adaptive clinical trials via semiparametric model 2020 ·The International Journal of Biostatistics ·(unknown), Ao Yuan, Ming Tan	0
9	Integrative analysis with a system of semiparametric projection non-linear regression models 2020 ·The International Journal of Biostatistics ·Ao Yuan, (unknown), Hong‐Bin Fang, Ming Tan	1
10	Expression and role of granulocyte macrophage colony-stimulating factor receptor (GM-CSFR) and granulocyte colony-stimulating factor receptor (G-CSFR) on Ph-positive acute B lymphoblastic leukemia 2018 ·Hematology ·Ming Tan, Meiling Chen, Yuanzhong Chen, Yong Wu	2
11	Adaptive Design for Staggered-Start Clinical Trial 2015 ·The International Journal of Biostatistics ·Ao Yuan, Qizhai Li, (unknown), Ming Tan	0
12	Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia 2013 ·Clinical Cancer Research ·Ivana Gojo, Ming Tan, Hong‐Bin Fang, Mariola Sadowska, Rena G. Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, (unknown), Rahul Srivastava, Igor Espinoza‐Delgado, Douglas D. Ross	40
13	The gene expression profile of preclinical autoimmune arthritis and its modulation by a tolerogenic disease-protective antigenic challenge 2011 ·Arthritis Research & Therapy ·Hua Yu, Changwan Lu, Ming Tan, Kamal D. Moudgil	6
14	Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients 2009 ·Cancer Prevention Research ·(unknown), Marshall R. Posner, Lisa M. Schumaker, Ming Tan, Mohan Suntharalingam, Olga Goloubeva, Scott E. Strome, Robert I. Haddad, (unknown), (unknown), Nicholas J. Sarlis, Jochen H. Lorch, Kevin J. Cullen	221
15	Validating a Nonacupoint Sham Control for Laser Treatment of Knee Osteoarthritis 2009 ·Photomedicine and Laser Surgery ·Ling Zhao, Xueyong Shen, Ke Cheng, Haiping Deng, Guanghong Ding, Ming Tan, Lixing Lao	19
16	Regularized (bridge) logistic regression for variable selection based on ROC criterion 2009 ·Statistics and Its Interface ·Hong‐Bin Fang, Zhenqiu Liu, Ming Tan, Guo‐Liang Tian	7
17	THE NESTED DIRICHLET DISTRIBUTION AND INCOMPLETE CATEGORICAL DATA ANALYSIS 2009 ·Statistica Sinica ·Kai Wang Ng, Man‐Lai Tang, (unknown), Ming Tan	5
18	A sequential procedure for monitoring clinical trials against historical controls 2006 ·Statistics in Medicine ·Xiaoping Xiong, Ming Tan, James M. Boyett	11
19	Hierarchical Models for Tumor Xenograft Experiments in Drug Development 2004 ·Journal of Biopharmaceutical Statistics ·Hong‐Bin Fang, Guo‐Liang Tian, Ming Tan	10
20	A unified approach to estimating association measures via a joint generalized linear model for paired binary data 2000 ·Communication in Statistics- Theory and Methods ·Yinsheng Qu, Ming Tan, Lisa Rybicki	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact